CoreCivic Raises 2026 Guidance After Strong Q1 Revenue of $614.7M, Net Income $37.9M
CXW sits 40% above its 52-week low of $15.735.
Summary
CoreCivic reported strong first-quarter 2026 results, with revenue reaching $614.7 million and net income of $37.9 million, leading the company to raise its full-year 2026 guidance. This positive performance was driven by the activation of four previously idled facilities and a substantial increase in ICE revenue, alongside the recent acquisition of Clinical Solutions Pharmacy for approximately $148 million. The upward revision of guidance signals management's increased confidence in future operational strength and profitability, building on the strong FY2025 results and initial 2026 guidance issued earlier this year. Traders will be watching for continued occupancy growth and the successful integration of the new acquisition as key catalysts.
At the time of this announcement, CXW was trading at $22.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $2.1B. The 52-week trading range was $15.74 to $23.54. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.